Evidence map›Paper›PMID 42371192›Full record

ReviewTechniques in coloproctology2026

When nothing else matters: proctectomy for complex perianal Crohn's disease-indications, timing, techniques, and outcomes.

T Yamamoto

Abstract readReview
In one paragraph

Review in Techniques in coloproctology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

T YamamotoInflammatory Bowel Disease Center, Yokkaichi Hazu Medical Center, 10-8 Hazuyamacho, Yokkaichi, Mie, 510-0016, Japan. takayukiyamamoto@hotmail.co.jp.ORCID http://orcid.org/0000-0001-7551-5568

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex perianal fistulizing Crohn's disease may progress to a functionally end-stage anorectum characterized by refractory proctitis, fixed anorectal stenosis/stricture, cavitating or recurrent pelvic sepsis, and complex branching fistulas, where repeated local salvage offers diminishing returns. This narrative review synthesizes predominantly observational evidence and consensus guidance on indications, timing, operative strategy, and outcomes of definitive proctectomy/abdominoperineal resection (APR). Decision-making should be structured and time-bound: Define anatomy and occult sepsis with pelvic magnetic resonance imaging (MRI) and examination under anesthesia (EUA), and perform EUA-guided biopsy when malignancy is suspected or surveillance is impractical. When reversibility is uncertain, planned temporary diversion can be used as a 3-6-month trial with explicit targets and stop rules; failure to meet milestones should prompt timely discussion of definitive resection. Operative choice (proctectomy/APR versus proctocolectomy) and dissection plane (close intersphincteric versus wider excision beyond the sphincter complex) should prioritize complete excision of chronically infected tissue and oncologic safety. Because perineal wound morbidity and persistent perineal sinus are common, outcomes depend on preoperative optimization, explicit dead-space/closure planning (primary closure, delayed management, omentoplasty, or flap reconstruction), and a postoperative pathway for early imaging and stepwise salvage. Appropriately timed surgery can provide durable control of sepsis and pain and reduce recurrent urgent interventions.

Indexed as

Crohn DiseaseProctectomyRectal FistulaHumansPerineumTime FactorsTreatment OutcomeAbdominoperineal resectionCrohn’s diseaseFecal diversionPerianal fistulaPersistent perineal sinusProctectomy

Identifiers

PMID42371192
PMCPMC13582050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.